News
Clinical Trials Arena on MSN21h
Sarepta refuses to pull gene therapy despite FDA orderSarepta Therapeutics is refusing to pull its gene therapy Elevidys (delandistrogene moxeparvovec), despite a request from the FDA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback